MapMan terms associated with a binding site
- Binding site
- Matrix_503
- Name
- AT2G37430;AT3G53600
- Description
- N/A
- #Associated genes
- 44
- #Associated MapMan terms
- 28
Click table-header(s) to enable sorting
MapMan | Description | #Associated genes | ath | bra | cme | egr | gma | ptr | ppe | sly | stu | vvi |
---|---|---|---|---|---|---|---|---|---|---|---|---|
27 | RNA | 8 (18.18%) | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 0 |
27.3 | RNA.regulation of transcription | 7 (15.91%) | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 |
26 | misc | 2 (4.55%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
26.7 | misc.oxidases - copper, flavone etc | 2 (4.55%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
27.3.6 | RNA.regulation of transcription.bHLH,Basic Helix-Loop-Helix family | 2 (4.55%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
27.3.99 | RNA.regulation of transcription.unclassified | 2 (4.55%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
28 | DNA | 2 (4.55%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
28.99 | DNA.unspecified | 2 (4.55%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
30 | signalling | 2 (4.55%) | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
10 | cell wall | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
10.7 | cell wall.modification | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
17 | hormone metabolism | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
17.6 | hormone metabolism.gibberelin | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
17.6.2 | hormone metabolism.gibberelin.signal transduction | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
27.3.2 | RNA.regulation of transcription.Alfin-like | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
27.3.25 | RNA.regulation of transcription.MYB domain transcription factor family | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
27.3.3 | RNA.regulation of transcription.AP2/EREBP, APETALA2/Ethylene-responsive element binding protein family | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
27.4 | RNA.RNA binding | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
29 | protein | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
29.4 | protein.postranslational modification | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
29.5.11.4.2 | protein.degradation.ubiquitin.E3.RING | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
30.2 | signalling.receptor kinases | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
30.2.3 | signalling.receptor kinases.leucine rich repeat III | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
30.5 | signalling.G-proteins | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
31 | cell | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
31.1 | cell.organisation | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
33 | development | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
33.99 | development.unspecified | 1 (2.27%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |